Literature DB >> 2078050

Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug.

E F Sherertz1, K B Sloan, R G McTiernan.   

Abstract

A 2% commercial solution formulation of 5-fluorouracil (5-FU) was significantly better at delivering 5-FU than either a 1% or 5% solution. Among single component suspension formulations the highest transdermal delivery was obtained from the vehicle in which 5-FU was least soluble, isopropyl myristate (IPM), while changes in the total suspended concentration of 5-FU in propyleneglycol (PG) had no significant effect on transdermal delivery by those suspensions. A prodrug of 5-FU/IPM was significantly better at delivering 5-FU than any of the formulations. The trends in relative rates of delivery of 5-FU by the formulations and the prodrug were the same in skin of hairless mice and humans. The mouse skin was about ten times more permeable than the human skin. Second application studies to assess skin damage caused by the formulations also showed the same trend in skin of hairless mice and humans: all of the formulations caused some damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078050     DOI: 10.1007/BF00402624

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  12 in total

1.  Treatment of solar keratoses of the extremities with retinoic acid and 5-fluorouracil.

Authors:  T A Robinson; A M Kligman
Journal:  Br J Dermatol       Date:  1975-06       Impact factor: 9.302

2.  SELECTIVE CYTOTOXIC EFFECT OF TOPICAL 5-FLUOROURACIL.

Authors:  C J DILLAHA; G T JANSEN; W M HONEYCUTT; A C BRADFORD
Journal:  Arch Dermatol       Date:  1963-09

3.  Penetration of 5-fluorouracil in excised skin.

Authors:  J L Cohen; R B Stoughton
Journal:  J Invest Dermatol       Date:  1974-05       Impact factor: 8.551

4.  Membrane diffusion. 3. Influence of solvent composition and permeant solubility on membrane transport.

Authors:  G L Flynn; R W Smith
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

5.  Further studies with topical 5-fluorouracil.

Authors:  C J Dillaha; G T Jansen; W M Honeycutt; G A Holt
Journal:  Arch Dermatol       Date:  1965-10

6.  Vehicle effect on topical drug delivery. II. Concurrent skin transport of drugs and vehicle components.

Authors:  B Møllgaard; A Hoelgaard
Journal:  Acta Pharm Suec       Date:  1983

Review 7.  Topical chemotherapy with 5-fluorouracil. A review.

Authors:  D K Goette
Journal:  J Am Acad Dermatol       Date:  1981-06       Impact factor: 11.527

8.  Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: dimethyl sulfoxide mediation of vidarabine (ara-A) permeation of hairless mouse skin.

Authors:  T Kurihara-Bergstrom; G L Flynn; W I Higuchi
Journal:  J Invest Dermatol       Date:  1987-09       Impact factor: 8.551

9.  Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil.

Authors:  E F Sherertz; K B Sloan; R G McTiernan
Journal:  J Invest Dermatol       Date:  1987-08       Impact factor: 8.551

10.  Effect of skin pretreatment with vehicle alone or drug in vehicle on flux of a subsequently applied drug: results of hairless mouse skin and diffusion cell studies.

Authors:  E F Sherertz; K B Sloan; R G McTiernan
Journal:  J Invest Dermatol       Date:  1987-09       Impact factor: 8.551

View more
  1 in total

1.  The effect of 5-fluorouracil on inhibition of epidermal DNA synthesis in vivo: a comparison of the effect of formulations and a prodrug of 5-FU.

Authors:  K B Sloan; E F Sherertz; R G McTiernan
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.